Novel neuroprotective and hepatoprotective effects of citric acid in acute malathion intoxication  by Abdel-Salam, Omar M.E. et al.
HOSTED BY Contents lists available at ScienceDirect
Asian Paciﬁc Journal of Tropical Medicine 2016; 9(12): 1181–1194 1181Asian Paciﬁc Journal of Tropical Medicine
journal homepage: http://ees.elsevier.com/apjtmOriginal research http://dx.doi.org/10.1016/j.apjtm.2016.11.005✉First and corresponding author: Omar M.E. Abdel-Salam, Department of
Toxicology and Narcotics, National Research Centre, Cairo, Egypt.
E-mail: omasalam@hotmail.com
Peer review under responsibility of Hainan Medical University.
1995-7645/Copyright © 2016 Hainan Medical University. Production and hosting by Elsevier B.V. This is an open access arti
creativecommons.org/licenses/by-nc-nd/4.0/).Novel neuroprotective and hepatoprotective effects of citric acid in acute malathion intoxicationOmar M.E. Abdel-Salam1✉, Eman R. Youness2, Nadia A. Mohammed2, Noha N. Yassen3, Yasser A. Khadrawy4,
2 5Saﬁnaz Ebrahim El-Toukhy , Amany A. Sleem
1Department of Toxicology and Narcotics, National Research Centre, Tahrir St., Dokki, Cairo, Egypt
2Department of Medical Biochemistry, National Research Centre, Tahrir St., Dokki, Cairo, Egypt
3Department of Pathology, National Research Centre, Tahrir St., Dokki, Cairo, Egypt
4Department of Physiology, National Research Centre, Tahrir St., Dokki, Cairo, Egypt
5Department of Pharmacology, National Research Centre, Tahrir St., Dokki, Cairo, EgyptARTICLE INFO
Article history:
Received 18 Jul 2016
Received in revised form 19 Aug
2016
Accepted 18 Sep 2016
Available online 10 Nov 2016
Keywords:
Citric acid
Malathion
Oxidative stress
Paraoxonase 1
Cholinesterase
Comet assayABSTRACT
Objective: To study the effect of citric acid given alone or combined with atropine on
brain oxidative stress, neuronal injury, liver damage, and DNA damage of peripheral
blood lymphocytes induced in the rat by acute malathion exposure.
Methods: Rats were received intraperitoneal (i.p.) injection of malathion 150 mg/kg
along with citric acid (200 or 400 mg/kg, orally), atropine (1 mg/kg, i.p.) or citric acid
200 mg/kg + atropine 1 mg/kg and euthanized 4 h later.
Results: Malathion resulted in increased lipid peroxidation (malondialdehyde) and nitric
oxide concentrations accompanied with a decrease in brain reduced glutathione, gluta-
thione peroxidase (GPx) activity, total antioxidant capacity (TAC) and glucose concen-
trations. Paraoxonase-1, acetylcholinesterase (AChE) and butyrylcholinesterase activities
decreased in brain as well. Liver aspartate aminotransferase and alanine aminotransferase
activities were raised. The comet assay showed increased DNA damage of peripheral
blood lymphocytes. Histological damage and increased expression of inducible nitric
oxide synthase (iNOS) were observed in brain and liver. Citric acid resulted in decreased
brain lipid peroxidation and nitric oxide. Meanwhile, glutathione, GPx activity, TAC
capacity and brain glucose level increased. Brain AChE increased but PON1 and
butyrylcholinesterase activities decreased by citric acid. Liver enzymes, the percentage of
damaged blood lymphocytes, histopathological alterations and iNOS expression in brain
and liver was decreased by citric acid. Meanwhile, rats treated with atropine showed
decreased brain MDA, nitrite but increased GPx activity, TAC, AChE and glucose. The
drug also decreased DNA damage of peripheral blood lymphocytes, histopathological
alterations and iNOS expression in brain and liver.
Conclusions: The study demonstrates a beneﬁcial effect for citric acid upon brain
oxidative stress, neuronal injury, liver and DNA damage due to acute malathion exposure.1. Introduction
Oxygen derived free radicals are produced in the cell from
many sources. One important source is the mitochondrial elec-
tron transport chain where electrons that leaked from O2 result in
generation of superoxide anion radical. (O2−). The redox state
of the cell is kept in balance due to a number of antioxidantmechanisms. These include both enzymatic (eg., catalases,
speroxide dismutases, and glutathione peroxidase) and non-
enzymatic free radical scavengers (eg., glutathione, a-tocoph-
erol, ascorbic acid) [1,2]. Oxidative stress develops when there is
an increase in oxidants and/or in adequate antioxidants [3].
Oxidative stress contributes to the development of several
disease processes eg., diabetes mellitus, cardiovascular disease,
cancer, neurodegenerative and psychiatric disorders [4–7].
Owing to its high metabolic demand, the brain utilizes much
O2 with the consequent increased generation of reactive
oxygen metabolites. Moreover, auto-oxidation of braincle under the CC BY-NC-ND license (http://
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of redox-active metals capable of catalyzing free radical re-
actions increase the brain' oxidant burden. The brain is also rich
in polyunsaturated fatty acids, which is the preferred substrate
for free radical attack. These factors coupled with modest anti-
oxidant mechanisms make the brain tissue particularly suscep-
tible to oxidative stress [1,2,8].
Reactive oxygen metabolites are likely to contribute to the
neurotoxic effects of organophosphate insecticides. In this
context, exposure to malathion caused increased lipid peroxida-
tion [9,10] increased nitric oxide, and decreased reduced
glutathione (GSH) [10] in the rat brain. Lipid peroxidation
increased in blood, liver [11,12] and in the rat erythrocytes as
well [13]. Studies also indicated decreased activities of the
antioxidant enzymes glutathione reductase and glutathione
peroxidase in rat cerebral cortex [14] and activities of superoxide
dismutase, catalase and glutathione peroxidase in human
erythrocytes [15] also decreased after exposure to malathion.
Moreover, the chain breaking antioxidants a-tocopherol and
ascorbate were able to reduce lipid peroxidation and ameliorate
the changes in antioxidant enzymes caused by malathion in rat
and human erythrocytes [13,15].
Citric acid (2-hydroxy-1,2,3-propane-tricarboxylic acid) is a
weak organic acid found in all animal tissues [16]. Cellular citrate
is synthesized inside the mitochondria [17] while rich dietary
sources include lemon, orange, tangerine and grapefruit [18].
Intracellular citric acid is important in the intermediary energy
metabolism of the cell. Citrate is produced in the mitochondria
from acetyl-CoA and oxaloacetate and enters the citric acid
cycle (tricarboxylic acid cycle or Krebs cycle). The resulting
high-energy intermediates; the reduced coenzymes nicotinamide
adenine dinucleotide and ﬂavin adenine dinucleotide are then
utilized in the respiratory chain in the inner mitochondrial
membrane to make ATP (adenosine 50-triphosphate) for the
cell's energy needs. Citric acid released into the cytoplasm via
speciﬁc mitochondrial carriers is converted to acetyl CoA for the
biosynthesis of fatty acids, lipids, and cholesterol [19].
Besides its role in the generation of energy, citrates have
other important actions including down regulation of inﬂam-
mation and reduction of lipid peroxidation [20–23]. Citrate
reduces polymorphonuclear cell degranulation and attenuate
the release of inﬂammatory mediators eg., myeloperoxidase,
platelet factor 4, interleukin 1b [18–20] and tumor necrosis
factor-alpha [23]. Citric acid displayed hepatoprotective effects
where it reduced hepatocellular damage evoked by carbon
tetrachloride in rats [24,25]. It also decreased brain lipid
peroxidation and inﬂammation and liver damage in mice
treated with bacterial lipopolysaccharide endotoxin [23].
A defect in mitochondrial bioenergetics might be involved in
the neurotoxic effects of malathion. This is because organo-
phosphates can cause mitochondrial impairment [9,26–29].
Moreover, the administration of methylene blue, an
antioxidant [30] and an enhancer of the electron transport chain
[31] protected against the malathion-induced neurotoxicity [10].
Thus, in view of the bioenergetic, antioxidant and anti-
inﬂammatory effects reported above for citrate, it looked perti-
nent to investigate the effect of citric acid administration on
oxidative stress and brain damage in rats intoxicated with the
organophosphate malathion. We also examined the possible
modulation by citric acid of the effect of atropine, the muscarinic
receptor antagonist and the antidote employed in the manage-
ment of acute organophosphate poisoning [32,33]. Since,malathion has been shown to cause hepatocellular damage
[34,35], the study was extended to include the liver tissue.
2. Materials and methods
2.1. Animals
Male rats of the Sprague–Dawley strain with body weight of
(130–140) g were used. Rats were obtained from Animal House
Colony of the National Research Centre. Rats allowed free ac-
cess to standard laboratory food and water. Animal procedures
were done in accordance to the recommendations of the insti-
tutional Ethics Committee and the National Institutes of Health
Guide for Care and Use of Laboratory Animals (Publication No.
85-23, revised 1985).
2.2. Drugs and chemicals
Malathion (Commercial grade, 57%) was purchased from El-
Naser Chemical Co., Cairo. Citric acid and atropine were ob-
tained from Sigma–Aldrich (St Louis, MO, USA). Other
chemicals and reagents were of analytical grade and purchased
from Sigma–Aldrich.
2.3. Study design
Rats were randomly divided into different groups (6 rat/
group). Group 1 was treated with i.p. saline (0.2 mL/rat) and
served as negative control. Group 2–6 were i.p. treated with
malathion at a dose of 150 mg/kg, along with saline (group 2),
citric acid at 200 or 400 mg/kg (groups 3&4), atropine at 1 mg/
kg (group 5) or citric acid at 200 mg/kg + atropine at 1 mg/kg
(group 6). Rats were euthanized by decapitation 4 h after drug
administration. Their brains were quickly removed on ice-plate
and washed with ice-cold phosphate-buffered saline at pH 7.4.
Brains were weighed and stored at −80 C for later biochemical
analyses. Homogenization of brain tissues were carried out using
0.1 M phosphate buffer saline (pH 7.4) to give a ﬁnal concen-
tration of 20% w/v for the biochemical assays.
2.4. Biochemical analyses
2.4.1. Lipid peroxidation
Malondialdehyde (MDA), a product of lipid peroxidation
was determined in tissue homogenates by the method of Nair
and Turne [36]. In this assay thiobarbituric acid reactive
substances (TBA) react with thiobarbituric acid to form TBA-
MDA adduct which can be measured colorimetrically at
532 nm.
2.4.2. Reduced glutathione
Reduced glutathione (GSH) was determined in tissue ho-
mogenates using the method of Ellman et al. [37]. The procedure
is based on the reduction of Ellman's reagent [DTNB; 5, 50-
dithiobis (2-nitrobenzoic acid)] by the free sulfhydryl group on
GSH to form yellow colored 5-thio-2-nitrobenzoic acid which
can be determined using spectrophotometer at 412 nm.
2.4.3. Nitric oxide
Nitric oxide was determined using colorimetric assay where
nitrate is converted to nitrite via nitrate reductase. Griess reagent
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can be determined using spectrophotometer [38].
2.4.4. Glutathione peroxidase activity
Glutathione peroxidase (GPx) activity was determined in su-
pernatants using colorimetric glutathione peroxidase kit (Bio-
diagnostic, Egypt). The activity of GPx is expressed as mU/mL.
2.4.5. Paraoxonase-1 activity
Paraoxonase-1 arylesterase activity was measured using
phenylacetate as a substrate and the formation of phenol was
measured spectrophotometrically by monitoring the increase in
absorbance at 270 nm at 25 C. One unit of arylesterase activity
is deﬁned as 1 mM of phenol formed per minute. Enzyme ac-
tivity was calculated based on the extinction coefﬁcient of
phenol of 1310 M−1 cm−1 at 270 nm, pH 8.0 and 25 C and
expressed kilo International Unit/Liter (kU/L) [39,40].
2.4.6. Acetylcholinesterase activity
Acetylcholinesterase activity was measured using the method
of Ellman et al. [41,42]. The method uses DTNB to measure the
amount of thiocholine produced as acetylthiocholine is
hydrolyzed by AChE. The color of DTNB adduct can be
measured using spectrophotometric at 412 nm. AChE activity
was expressed as mmol sulfhydryl (SH) groups/g tissue/min.
2.4.7. Butyrylcholinesterase activity
Butyrylcholinesterase (EC 3.1.1.8; BChE) activity was
measured in brain supernatants using commercially available kit
from Ben Biochemical Enterprise (Milan, Italy). The method is
that of Ellman et al. [41]. Butyrylcholinesterase catalyzes the
hydrolysis of butyrylthiocholine as substrate into butyrate and
thiocholine. Thiocholine reacts with 5, 50-dithiobis (2-
nitrobenzoic acid) (DTNB) forming a yellow chromophore
which can be quantiﬁed using spectrophotometer.
2.4.8. Total antioxidant capacity
Total antioxidant capacity (TAC) was measured in brain
homogenates using a colorimetric kit obtained from Bio-
diagnostic (Egypt). In this method antioxidants in the sample
react with a deﬁned amount of exogenously provided hydrogen
peroxide. The remaining hydrogen peroxide will be determined
calorimetrically by an enzymatic reaction which involves the
conversion of 3, 5-dichloro-2-hydroxy benzensulfate to a
colored product [29].
2.4.9. Glucose
Glucose oxidase catalyzes the oxidation of glucose to glu-
conic acid with the formation of hydrogen peroxide. The latter
reacts with phenol and 4-amino-antipyrine in the presence of
peroxidase resulting in a colored quinoneimine which can be
measured using spectrophotometer.
2.4.10. Liver enzymes
Reitman–Frankel procedure (Crowley 1967) was used for the
colorimetric determination of alanine aminotransferase (ALT)
and aspartate aminotransferase (AST) activities in liver. Alkaline
phosphatase (ALP) activity was determined colorimetrically ac-
cording to Belﬁeld and Goldberg (1971). Commercially available
kits from BioMe´rieux (France) were used for this purpose.2.5. Comet assay
Isolation of peripheral blood leukocytes were done by centri-
fugation (30 min at 1300 g) using Ficoll–Paque density gradient
(Pharmacia LKB Biotechnology, Piscataway, NJ, USA). After
centrifugation, leukocytes were represented as a buffy coat, aspi-
rated and washed twice with phosphate buffered saline (pH 7.4).
The comet assay was done at low temperature to minimize
spontaneous DNA damage [44,45]. In brief, 100 mL of normal
melting point agarose (at 0.7%) was applied onto a pre-cleaned
microscope charged slide and a coverslip was gently applied.
The coverslip was removed after the agarose solidiﬁed at 4 C and
100 mL of low melting point agarose at 0.5% containing 1500
peripheral blood lymphocytes were then added. The coverslip was
replaced and the slide placed at 4 C for solidiﬁcation. The
coverslip was then removed and a ﬁnal layer of low melting
agarose was added, coverslipped, and left to solidify for 10 min.
The coverslip was removed and the slide was immersed in
100 mL of fresh lysis buffer (2.5 mol/L NaCl, 100 mmol/L EDTA,
1% sodium hydroxide, 10 mmol/L Tris, 1% Triton X-100, 10%
DMSO (pH10)) at 4 C for 1 h. The microgels slides were then
removed from the solution and rinsed with DNA unwinding solu-
tion (300 mmol/L NaOH and 1 mmol/L EDTA, pH 13) for 30 min
at 4 C. Thereafter, the slides were placed on a horizontal gel
electrophoresis chamber that is ﬁlled with DNA-unwinding solu-
tion. Gels were run for 30 min with constant current of 300 mA at
4 C. Following electrophoresis, the microgels were neutralized
with 0.4 M Trisma base at pH 7.5 for 10 min and ﬁnally, the slides
were stained with 20 mL ethidium bromide (Sigma) at 10 mg/mL.
Examination of the slides was done at 400× magniﬁcation
using a ﬂuorescence microscope (IX70; Olympus, Tokyo,
Japan). The apparatus was equipped with an excitation ﬁlter of
549 nm and a barrier ﬁlter of 590 nm and attached to an
‘Olympus’ video camera. The damaged cell had the appearance
of a comet, with a brightly ﬂuorescent head and a tail to one side.
The latter formed by the DNA containing strand breaks that
were drawn away during electrophoresis. Samples were studied
by counting the number of damaged cell per 100 cells as to
calculate the percent of damaged cells.
2.6. Histological studies
The rats were killed by decapitation, and their brains and
livers were quickly removed out. Slices were then were ﬁxed in
10% formalin (pH 7.4) for a minimum of 72 h, washed in tap
water for 30 min, dehydrated using ascending grades of alcohol,
cleared in xylene and embedded in parafﬁn. Serial sections
(6 mm thick) were stained with hematoxylin and eosin (H&E),
examined and photographed under light microscope using a
digital camera (DP70, Tokyo). Adobe Photoshop version 8.0
was used for images processing.
2.7. Immunohistochemistry
Immunohistochemistry for iNOS was done on parafﬁn-
embedded sections that were deparafﬁnized and rehydrated. Sec-
tions were incubated in 0.3% H2O2 solution in methanol at room
temperature for 30 min to block endogenous peroxidase activity.
For antigen retrieval, sections were heated in a microwave oven at
720 W for 25 min and incubated with mouse monoclonal iNOS
antibodies (dilution 1:50) at 4 C overnight. Sections were then
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cubation with biotinylated goat-anti-rabbit-immunoglobulin G
secondary antibodies (dilution 1:200) and streptavidin/alkaline
phosphatase complex (dilution 1:200) (for 30 min at room tem-
perature). The binding sites of antibody were visualized with 3, 30-
diaminobenzidine. Sections were then rinsed with phosphate
buffered saline, counterstained with H&E for (2–3) min, and
dehydrated in ascending grades of ethanol. Slices were then
soaked twice in xylene at room temperature for 5 min, mounted,
and examined by light microscope.
2.8. Immunomorphometric analysis
Quantitative assessment of iNOS immunoreactivity was done
with an Image Analyzer system (Leica Qwin 500IW, Cam-
bridge, England).Figure 1. Oxidative stress markers in the brain of malathion-treated rats and t
*P < 0.05 compared with saline group. +P < 0.05 compared with malathion o2.9. Statistical analysis
Data are expressed as mean ± SE. Statistical signiﬁcance was
determined using one-way analysis of variance (ANOVA), fol-
lowed by Duncan's multiple range test (SPSS software; SAS
Institute Inc., Cary, NC). A probability value of less than 0.05
was considered statistically signiﬁcant.3. Results
3.1. Oxidative stress
3.1.1. Lipid peroxidation
In brain tissue, lipid peroxidation measured as malondialde-
hyde (MDA) showed signiﬁcant increase by 45%after exposure tohe effect of citric acid, atropine or citric acid combined with atropine.
nly group. #P < 0.05 compared with malathion + atropine group.
Figure 2. Oxidative stress markers in the liver tissue of malathion-treated
rats and the effect of citric acid, atropine or citric acid combinedwith atropine.
*P < 0.05 compared with saline group. +P < 0.05 compared with malathion
only group. #P < 0.05 compared with malathion + atropine group.
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vs. (20.00 ± 0.84) nmoL/g tissue. In rats treated with malathion,
citric acid at 200 and 400mg/kg resulted in signiﬁcant decrease in
the level of MDA by 14.8% and 18.6%, respectively
(24.70 ± 0.92) and (23.60 ± 1.10) vs. (29.00 ± 1.20) nmoL/g tissue.
No signiﬁcant effect was observed for atropine but the combined
treatment with atropine and citric acid reduced MDA by 41%
compared with the malathion only group (17.10 ± 1.30) vs.
(29.00 ± 1.20) nmoL/g tissue (Figure 1A).
In liver tissue, malathion induced a marked increase in
membrane lipid peroxidation, as shown by the level of MDA
(55.5% increase: saline control, (51.9 ± 2.1); malathion
(80.7 ± 4.9) nmoL/g tissue). A signiﬁcant decrease in MDA by
16.4% and 26.9% was observed after treatment with 200 mg/kg
citric acid and after both atropine and citric acid (59.0 ± 3.7) and
(67.4 ± 3.6) vs. (80.7 ± 4.9) nmoL/g tissue (Figure 2A).
3.1.2. Nitrite
Malathion induced a signiﬁcant rise in the level of brain nitrite
by 42% compared with the saline group (27.4 ± 2.2) vs.
(19.3 ± 1.6) mmol/g tissue. Treatment with citric acid signiﬁcantly
reduced brain nitrite by 28.8% and 33.9%, respectively, compared
with the malathion only treatment group (19.5 ± 0.9) and
(18.1 ± 1.3) vs. (27.4 ± 2.2) mmol/g tissue. A signiﬁcant decrease
in brain nitrite by 37.2% and 35%was also observed in rats treated
with either atropine or atropine and citric acid (17.2 ± 1.0) and
(17.80 ± 0.68) vs. (27.4 ± 2.2) mmoL/g tissue (Figure 1B).
In the liver tissue of malathion only treated rats, a signiﬁcant
increase in nitrite was also observed as 39.3% increase: saline
control, (44.0 ± 2.6); malathion (61.3 ± 4.0) mmoL/g tissue. The
administration of citric acid, atropine or their combination,
however, had no signiﬁcant effect on liver MDA (Figure 2B).
3.1.3. Reduced glutathione
Compared with the saline control group, the level of brain
GSH decreased by 29.8% in the malathion only treated rats
(3.40 ± 0.11) vs. (4.83 ± 0.24) mmol/g tissue. Brain GSH showed
signiﬁcant rise by 19.1% and 23.5% after treatment with citric
acid at 200 and 400 mg/kg, respectively (4.05 ± 0.12) and
(4.20 ± 0.18) vs. (3.40 ± 0.11) mmol/g tissue. The administration
of atropine alone or combined with citric acid, however, had no
signiﬁcant effect on brain GSH (Figure 1C).
A signiﬁcant decrease in GSH by 30.4% was also observed in
the liver of malathion only treated rats (8.00 ± 0.25) vs.
(11.50 ± 0.61) mmol/g tissue. Rats treated with 200 m/kg citric
acid or both atropine and citric acid had 17% and 17.5% in-
crements in liver GSH compared with the malathion only treated
group (9.36 ± 0.21) and (9.42 ± 0.3) vs. (8.00 ± 0.25) mmol/g
tissue (Figure 2C).
3.2. Glutathione peroxidase activity
Malathion resulted in a signiﬁcant decrease in brain GPx
activity by 44.9% saline control, (83.9 ± 3.5); malathion
(46.2 ± 2.9) mU/mL. Rats treated with citric acid showed sig-
niﬁcant increments in GPx activity by 67.3% and 79%,
respectively, compared with the respective malathion only
control group (77.3 ± 4.0) and (82.7 ± 4.3) vs. (46.2 ± 2.9) mU/
mL. A signiﬁcant increase in brain GPx activity by 47.2% and
47.4% was also observed in rats treated with malathion along
with atropine or both atropine and citric acid compared with themalathion only control group (68 ± 3.0) and (68.1 ± 3.6) vs.
(46.2 ± 2.9) mU/mL (Figure 1D).
3.3. Total antioxidant capacity
Rats treated with only malathion had signiﬁcantly decreased
TAC in their brains by 62.5% compared with their saline control
counterparts (0.268 ± 0.010) vs. (0.714 ± 0.060) mmol/g tissue.
A signiﬁcant increase in brain TAC by 27.2%, 58.9% and 37.3%
was observed in rats treated with malathion along with 400 mg/
kg citric acid, atropine or both atropine and citric acid compared
Figure 4. Butyrylcholinesterase (BChE) activity in the brain of malathion-
treated rats and the effect of citric acid, atropine or citric acid combined
with atropine.
*P < 0.05 compared with saline group. +P < 0.05 compared with mala-
thion only group.
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(0.426 ± 0.030) and (0.368 ± 0.020) vs. (0.268 ± 0.010) mmol/g
tissue (Figure 1E).
3.4. Acetylcholinesterase activity
Rats treated with only malathion showed 30.7% inhibition in
brain AChE activity compared with the saline control group
(4.71 ± 0.23) vs. (6.80 ± 0.41) mmoL SH/g/min. A signiﬁcant
increase in brain AChE activity by 47.1%, 32.9%, and 25.3%
was observed in rats treated with malathion along with 400 mg/
kg citric acid, atropine or both atropine and citric acid compared
with the malathion only control group (6.93 ± 0.47),
(6.26 ± 0.22) and (5.90 ± 0.31) vs. (4.71 ± 0.23) mmol SH/g/
min (Figure 3).
3.5. Butyrylcholinesterase activity
In malathion only-treated rats, brain BChE activity was
inhibited by 38.2% compared with the saline control group
(120.51 ± 7.60) vs. (195.14 ± 13.70) U/L. Further signiﬁcant
decrease in brain BChE activity by 24.4%, and 24.5% was
observed in rats treated with malathion along with 400 mg/kg
citric acid or both atropine and citric acid compared with the
malathion only control group (91.1 ± 6.0) and (91.0 ± 4.8) vs.
(120.51 ± 7.60) U/L (Figure 4).
3.6. Paraoxonase-1 activity
Compared with the saline control group, malathion only-
treated rats showed a signiﬁcant inhibition of brain PON1 ac-
tivity by 36.9% (7.95 ± 0.54) vs. (12.6 ± 0.42) kU/L. No sig-
niﬁcant effect for atropine was observed on PON1 activity in
malathion-treated rats. The enzyme activity in the brain, how-
ever, showed further inhibition by 19.1%, 23.3% and 24.9%
following treatment with citric acid at 200 or 400 mg/kg and
both atropine and citric acid compared with the malathion only
control group (Figure 5A). In the liver tissue, malathion caused
34.8% inhibition in PON1 activity (21.7 ± 1.2) vs.
(33.27 ± 1.60) kU/L. There was no signiﬁcant effect for citric
acid alone on PON1 activity in malathion-treated rats. TreatmentFigure 3. Acetylcholinesterase (AChE) activity in the brain of malathion-
treated rats and the effect of citric acid, atropine or citric acid combined
with atropine.
*P < 0.05 compared with saline group. +P < 0.05 compared with mala-
thion only group.with only atropine inhibited the activity of the enzyme by 20.6%
(17.23 ± 0.83) vs. (21.7 ± 1.2) kU/L, whereas citric acid in
combination with atropine increased PON1 activity by 26.7%
compared with the malathion only control group (27.5 ± 1.5) vs.
(21.7 ± 1.2) kU/L (Figure 5B).Figure 5. Paraoxonase-1 (PON-1) activity in the brain and liver of
malathion-treated rats and the effect of citric acid, atropine or citric acid
combined with atropine.
+P < 0.05 compared with malathion only group. #P < 0.05 compared with
malathion + atropine group.
Figure 6. Brain glucose level in rats treated with malathion and the effect
of citric acid, atropine or citric acid combined with atropine.
*P < 0.05 compared with saline group. +P < 0.05 compared with mala-
thion only group. #P < 0.05 compared with malathion + atropine group.
Figure 7. AST and alanine ALT activities in the liver tissue of malathion-trea
atropine.
*P < 0.05 compared with saline group and between different groups as indicate
compared with malathion + citric acid.
Figure 8. Representative ﬂuorescence images of comets from blood lymphocy
A and B: malathion (control); C: malathion + citric acid 200 mg/kg; D: malathio
malathion + citric acid 200 mg/kg + atropine 1 mg/kg.
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Compared with the saline-treated rats, a signiﬁcant decrease
in brain glucose concentrations by 30.6% was observed in the
malathion only treated group (218.0 ± 13.0) vs. (314.0 ± 9.6) mg/
g tissue. A signiﬁcant increase in glucose concentrations by
69.3%, 49.7%, 33.9%, and 97.2%, respectively, was observed in
brain of rats treated with malathion along with (200–400) mg/kg
citric acid, atropine or both atropine and citric acid compared
with the malathion only control group (Figure 6).
3.8. Liver enzymes
Results are presented in Figure 7. Malathion caused signiﬁ-
cant elevation in liver ALT and AST by 83.9% and 130.8%,
respectively compared with saline-treated rats (84.6 ± 4.1) vs.
(46.0 ± 3.2) and (83.1 ± 3.7) vs. (36.0 ± 1.9) U/g tissue. Citric
acid given at 200 and 400 mg/kg signiﬁcantly decreased liverted rats and the effect of citric acid, atropine or citric acid combined with
d in the ﬁgure. +P < 0.05 compared with malathion only group. #P < 0.05
tes of malathion and citrate/atropine-treated rats.
n + citric acid 400 mg/kg; E and F: malathion + atropine 1 mg/kg; G and H:
Figure 9. The percentage of comets from blood lymphocytes of rats treated
withmalathion alone or combinedwith citric acid andor atropine.Means±SE.
*P < 0.05 compared with saline group. +P < 0.05 compared with malathion
only group. #P< 0.05 comparedwithmalathion + citric acid 200mg/kggroup.
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thion only group (65.4 ± 5.2) and (44.5 ± 2.1) vs. (84.6 ± 4.1) U/
g tissue. Meanwhile, there was 26% decrease in liver ALT by
citric acid at 400 mg/kg (61.5 ± 4.2) vs. (83.1 ± 3.7) U/gFigure 10. Hematoxylin and eosin (H&E) stained sections of cerebral cortex
Treated with (A) Saline: normal structure; the granular layer (curved yellow arro
(B) Malathion 150 mg/kg: lymphocytic inﬁltration (wavy arrows), destruction o
congested blood vessels (red arrow heads), and reactive gliosis (green stars
Malathion + atropine: generalized astrogliosis (thick red arrows). (F) Malathion
vessels (red arrow heads) (H&E × 200).tissue. In contrast, signiﬁcant increase in AST and ALT by 30%
and 67.3% was observed in malathion + atropine compared
with malathion only group. On the other hand, rats treated with
malathion + citric acid + atropine showed 14.3% and
29% increments in AST and ALT compared with malathion
only group.
3.9. Comet assay
Malathion injection induced DNA fragmentation in blood
lymphocytes. The comet percentage of lymphocytes in mala-
thion only treated rats was 83.5% ± 1.34% compared with
saline control value of 6.2% ± 0.47% (P < 0.05). Citric acid
administered at 200 or 400 mg/kg to malathion-treated rats
resulted in a dose-dependent decrease in the % of damaged
cells by 68.9% and 87.2% (26.00% ± 0.81%) and
(10.70% ± 0.98%) vs. (83.50% ± 1.34%). The comet percent-
age of peripheral blood lymphocytes after treatment with
atropine and citric acid + atropine was signiﬁcantly reduced by
85% and 86.8% compared with the malathion only group
(12.50% ± 0.56%) and (11.00% ± 0.71%) vs. (83.5% ± 1.34%)
(Figures 8 and 9).of rats.
w), Purkinje cell layer (yellow arrow) and the molecular layer (yellow star).
f Purkinje cells layer (short arrows). (C) Malathion + citric acid 200 mg/kg:
). (D) Malathion + citric 400 mg/kg: reactive gliosis (green stars). (E)
+ citric acid + atropine: normal glial tissue with minimal congested blood
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3.10.1. Brain
Rats treated with saline (control group) showed normal histo-
logical picture of brain tissue (Figure 10A). Rats treated with only
malathion showed marked changes in the form of meningitis and
lymphocytic inﬁltration associated with destruction of most of the
Purkinje cells layer (Figure 10B). On the other hand there was
marked improvement after the administration of citric acid
although congested blood vessels and reactive gliosis were seen
(Figure 10C andD). Rats treated withmalathion and only atropine
exhibited near normal brain tissue except for generalized astro-
gliosis as demonstrated by cellular hypertrophy (Figure 10E).
Sections from rats treated with malathion + citric acid + atropine
showed only congested blood vessels (Figure 10F).
3.10.2. Liver
Saline-treated rats showed normal histology of hepatic tissue
(Figure 11A). Rats treated with malathion showed liver struc-
tural damage along with disarrangement of hepatic lobules with
formation of ﬁbrotic strands. Necrosis and vacuole formation in
hepatocytes, sinusoidal enlargement, and leucocytic inﬁltration
were seen. Moreover, dilation and congested blood vessels with
hemorrhage were noted (Figure 11B). Rats treated with both
malathion and citric acid (200 mg/kg) exhibited improvedFigure 11. Hematoxylin and eosin (H&E) stained liver sections from rats.
Treated with (A) Saline: normal hepatic lobules; the central vein (long thin arro
arrows), ﬁbrotic strands (arrow heads), leucocytic inﬁltration (wavy arrows), and
minimal congestion of the central vein (thick arrow), vacuolated hepatocytes (
around hepatic vessels (wavy arrows), and minimally congested vessels (thick
congested hepatic vessels (thick arrow). (F) Malathion + citric acid + atropin
congested blood vessels (thick arrow) (H&E × 200).hepatic tissue structure, with minimal vacuolated hepatic cells
(Figure 11C). Treatment with the higher dose of citric acid
(400 mg/kg) improved hepatic cells except for minimal lym-
phocytic inﬁltration around the hepatic vessels (Figure 11D).
Meanwhile, rats given both malathion and atropine exhibited
near normal liver tissue with normal architecture and distinct
hepatic cells except for blood vessel dilatation (Figure 11E).
Likewise, rats treated with malathion, atropine and citric acids
showed only minimal congested hepatic vessels (Figure 11F).
3.11. Immunomorphometric analysis of iNOS
immunoreactivity
3.11.1. Brain
Figure 12 shows the mean optical density measurements of
iNOS immunoreactivity ± SE (%) in cerebral cortex of rats
treated with saline, malathion and malathion along with citric
acid and/or atropine. There was negligible iNOS expression in
the control group. Rats treated with only malathion exhibited
increased iNOS expression compared with the saline treated
group (213.6% increase: (4.92 ± 0.35) vs. (0.22 ± 0.10)). In
malathion-treated rats, citric acid caused a signiﬁcant and dose-
dependent decrease in iNOS immunoreactivity (63% and 95.3%
decrements: (1.82 ± 0.16), (0.23 ± 0.05) vs. (4.92 ± 0.35)). A
signiﬁcant and marked decrease in iNOS expression by 89.2%w), portal triad. (B) Malathion (150 mg/kg): congested blood vessels (thick
vacuolar hepatocytes (thin arrows). (C) Malathion + citric acid 200 mg/kg:
thin arrows). (D) Malathion + citric acid 400 mg/kg: leucocytic inﬁltration
arrow). (E) Malathion + atropine: well formed hepatic tissue and dilated
e: foci of inﬂammatory cells (wavy arrow), foci of necrotic tissue (star),
Figure 12. Optical density measurements of iNOS immunoreactivity ± SE
(%) in the cerebral cortex of rats treated with malathion and the effect of
citric acid, atropine or citric acid combined with atropine.
*P < 0.05 compared with saline group and between different groups as
shown on the graph. +P < 0.05 compared with malathion only group.
#P < 0.05 compared with malathion + citric acid 200 mg/kg group.
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combined with citric acid (0.53 ± 0.02), (1.162 ± 0.17) vs.
(4.92 ± 0.35).
3.11.2. Liver
Quantitative measurements of iNOS immunoreactivity in the
liver from rats exposed to malathion revealed marked and sig-
niﬁcant increase in iNOS immunoreactivity compared to the
saline-treated group 741.7% increase: (7.55 ± 0.17) vs.
(0.897 ± 0.120). Rats treated with malathion and citric acid
exhibited 92.4% and 89.8% decrements in iNOS immunoreac-
tivity, respectively, as compared with the malathion only group
(0.57 ± 0.10) and (0.773 ± 0.130) vs. (7.55 ± 0.17). Treatment
with atropine resulted in 98.4% decrease in iNOS immunore-
activity. Meanwhile, atropine combined with citric acid resulted
in 79.9% decrease in iNOS immunoreactivity as compared with
the malathion only group (1.516 ± 0.270) vs. (7.55 ± 0.17)
(Figure 13).Figure 13. Optical density measurements of iNOS immunoreactivity ± SE
(%) in the liver of rats exposed to malathion and the effect of citric acid,
atropine or citric acid combined with atropine.
*P < 0.05 compared with saline group and between different groups as
shown on the graph. +P < 0.05 compared with malathion only group.
#P < 0.05 compared with malathion + citric acid 200 mg/kg group.4. Discussion
Several recent studies indicated a role for reactive oxygen
metabolites and increased oxidative stress in the neurotoxic effects
of organophosphate insecticides [9,10,15]. In this study, the decrease
in reduced glutathione, GPx activity, TAC and the increase in the
lipid peroxidation product malondialdehyde is evidence of
increased generation of reactive oxygen metabolites and other
free radicals capable of inducing lipid peroxidation of the cell
membrane polyunsaturated fatty acids [4]. Organophosphates
result in increased free radicals either as a part of their
biotransformation or in the detoxiﬁcation pathway [46]. These
agents can also cause mitochondrial impairment [9,29], which
could lead to increased reactive oxygen species. The latter in
turn could result in further damage to the mitochondria, thereby,
generating a vicious circle [47,48]. In this context, malathion
caused the increased formation of superoxide anion in sub-
mitochondrial particles in hippocampus and inhibition of mito-
chondrial complex IV [9]. There was also a decrease in complex I
activity in the hippocampus of malathion-exposed animals [28].
Other organophosphates induced alterations in mitochondrial
dynamics such as increased mitochondrial length and reduced
number of mitochondria as well as impaired axonal transport.
These changes occurred at insecticide concentrations that failed
to affect acetylcholinesterase activity [27]. In this study we
hypothesized that citric acid by virtue of its antioxidant and
bioenergetic actions would be able to decrease the malathion-
induced neurotoxicity. Our ﬁndings validate this assumption.
We have shown that the concurrent administration of malathion
and citric acid resulted in markedly decreased neuronal damage
due to the insecticide. Brain MDA decreased after citric acid
administration and the decline inGSH,GPx activity andTACwere
all reduced by citric acid. DNA damage of peripheral blood lym-
phocytes was also markedly decreased. Moreover, the histopath-
ological alterations in the brain caused by malathion were
ameliorated by treatment with citric acid. The present study thus
suggests a novel action for citric acid in the protection against acute
malathion intoxication.
Citrate occupies a central role in cellular intermediary meta-
bolism. It occurs as an intermediate in the tricarboxylic acid or
Krebs cycle, which generates energy through the oxidation of
acetate. Energy in the form of reduced pyridine nucleotides are
then used in the mitochondrial respiratory chain for synthesis of
adenosine 50-triphosphate [17]. Energy derived through glycolysis
and tricarboxylic acid cycle is indispensable for maintaining
neuronal and astrocytic functions and integrity [49,50]. In their
study, Ying et al. [51] have shown that, excessive activation of
PRAP1. Excessive activation of PRAP1 induces neuronal and
astrocytes death by decreasing the levels of cytosolic NAD+ and
impairing glycolysis. Provision of the tricarboxylic acid cycle
substrates eg., a-ketoglutarate or pyruvate (though not glucose)
reduced this cell death [51]. In the same way, it is possible that a
reduction in brain metabolism is related to the neurotoxic
actions of malathion and this was amenable to treatment with
citrate.
Besides its bioenergetic role, intracellular citrate is also
important for the synthesis of fatty acids, isoprenoids and
cholesterol [52]. Citrate exerted anti-inﬂammatory actions eg.,
decreased release of myeloperoxidase, interleukin 1b, platelet
factor 4 and elastase [20–22,53]. Citrate also displayed
antioxidative effects reducing lipid peroxidation [21,23]. These
actions of citrate are likely to be involved in protecting brain
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suggested that citrate released by astrocytes may modulate
neuronal excitability by chelating Ca2+ and Mg2+ and thus
regulating their extracellular concentrations [54]. This might
provide another mechanism for the ability of citrate to protect
neurons from malathion. There is also an evidence for the
importance of cytoplasmic citrate availability in maintaining
genome stability. In their study, defects in the mitochondrial
citrate carrier SLC25A1 that releases citrate into the cytoplasm
resulted in chromosomal breaks [55].
In this study, malathion caused increased brain nitric oxide
and iNOS expression which decreased following treatment with
citric acid. These observations suggest a pivotal role for nitric
oxide in the development of malathion neurotoxicity. The
gaseous molecule nitric oxide has an important role in the brain
as intracellular messenger and in maintaining vascular tone
owing to its vasodilator action [56]. In brain tissue, the excessive
formation of nitric oxide in inﬂammatory and toxic states from
astrocytes and microglia by the inducible nitric oxide synthase
can lead to neuronal death. Increased activation of neuronal
nitric oxide synthase during certain pathological conditions
can also result in the release of excessive amounts of nitric
oxide and ensuing neurotoxicity. Nitric oxide itself is
relatively non-toxic, but can react with superoxide resulting in
the formation of the peroxynitrite radical (ONOOe), and also
with oxygen to yield NO2 and N2O3 capable of inducing lipid
peroxidation, oxidation or nitrosylation of thiols e.g. glutathione
or protein thiols and DNA damage [57,58]. Energy depletion
occurs because of an inhibitory action on cytochrome oxidase,
mitochondrial respiration, glycolysis, and the induction of
mitochondrial permeability transition [59].
In this study, we observed decreased arylesterase activity of
PON1 in the brain and liver of malathion exposed rats. The
enzyme PON1 hydrolyzes several organophosphorus com-
pounds, carbamates, nerve agents and many other xenobiotics
[60,61]. The catalytic efﬁciency of PON1 in hydrolyzing speciﬁc
organophosphate insecticides determines the individual's
susceptibility to these agents [62–65]. The activity of the enzyme
in plasma is also affected by exposure to organophosphate
insecticides and is associated with marked inhibition of plasma
BChE [66–68]. The PON1 enzyme also has an antioxidant action
[40] and a peroxidase-like activity [69]. Paraoxonase-1 is inacti-
vated by oxidants [70,71]. The decrease in enzyme activity by
malathion might thus involve oxidative modiﬁcation and/or
direct inhibition by the organophosphate. In brain tissue of
malathion-treated rats, the enzyme activity, however, showed
further inhibition by citric acid and byboth atropine and citric acid.
Similar changes were not observed in liver tissue where citric acid
alone had on PON1 activity in malathion-treated rats. These
ﬁndings might suggest that changes in enzyme activity are not
related to the protective action of citric acid in this study.
Organophosphate insecticides irreversibly bind to and inac-
tivate the enzyme cholinesterase [72]. In mammals, both AChE
and BChE hydrolyze the neurotransmitter acetylcholine but
with differing speciﬁcity. This neurotransmitter is present in
the post-synaptic neuronal membrane, at the myoneural junc-
tion, autonomic ganglia, and at the terminal endings of the post-
ganglionic parasympathetic nerves [73]. Organophosphates thus
results in acetylcholine accumulation at the neuronal synapse
and excessive central and peripheral cholinergic activity [72,73].
Whereas the role for AChE in hydrolyzing acetylcholine isclear, the physiological role of BChE is less obvious [74].
Butyrylcholinesterase also detoxiﬁes or catabolize ester-
containing drugs. Humans with BChE deﬁciency are asymp-
tomatic but exhibit increased sensitivity to the muscle relaxants
suxamethonium and mivacurium, two BChE substrates, used in
anesthesia [75]. In managing poisoning due to organophosphate,
the antidote atropine, a cholinergic receptor antagonist, is
frequently used to prevent the effects of excess acetylcholine
at the muscarinic cholinergic synapses [32,33]. In this study, we
demonstrate that atropine administered at time of exposure to
malathion was capable of increasing brain cholinesterase
activity and ameliorating the neuronal damage due to the
insecticide. The agent also effectively inhibited DNA damage
of peripheral blood lymphocytes. In the brain of malathion-
exposed rats, atropine inhibited iNOS expression and the
release of nitric oxide. Glutathione peroxidase activity and total
antioxidant capacity also increased following treatment with
atropine. These ﬁndings suggest a link between excessive
cholinergic stimulation and the development of oxidative stress
due to the organophosphate and that oxidative stress is a
consequence to increased cholinergic stimulation.
Glucose is the main energetic fuel for energy-dependent brain
functions and brain glucose consumption accounts for 45–60%
of glucose used by the body [76]. In this study, a decrease in
brain glucose in malathion-exposed rats was observed. It is
not clear whether this represents an increase in energy produc-
tion by neurons and astrocytes in face of the toxic challenge or is
the result of impaired glucose brain transport. Nevertheless, re-
covery of brain glucose in malathion-exposed rat occurred
following citrate, atropine or their combined administration,
suggesting a link between the restoration of brain glucose level
and neuroprotection by these agents.
In this study, the ability of malathion to cause DNA damage
of peripheral blood lymphocytes was determined using the
‘Comet assay’. This assay is useful for the detection of DNA
strand breaks in mammalian cells [44]. Our results conﬁrm
previous studies indicating increased the DNA damage in
peripheral blood of malathion-treated rats [77,78]. The number
of comets produced by malathion in peripheral blood
lymphocytes showed marked decrease in citric acid and/or
atropine-treated rats.
Studies have shown that exposure to malathion is able to
cause liver tissue damage which is mediated by free radicals
[34,35]. We thus extended our observations in order to delineate
an effect for citric acid on liver injury in malathion intoxicated
rats. Our results showed that malathion increased liver lipid
peroxidation and nitrite along with decreased GSH indicative
of increased oxidative stress. There were also increased liver
transaminases, a marker of liver cell damage. Only with citric
acid at 200 mg/kg or citric acid-atropine combined treatment,
there was decreased lipid peroxidation and an increase in hepatic
GSH while transaminases decreased after treatment with citric
acid at 400 mg/kg. These changes were not observed after
atropine. Nevertheless, histopathological studies indicated a
clear protective effect for citric acid, atropine, or their combi-
nation along with inhibition of iNOS expression in hepatocytes.
The liver lobule and hepatocytes thus regained their morpho-
logical integrity after treatment with citric and/or atropine. It is
likely; however, that functional recovery is not yet complete in
view of the still increased lipid peroxidation and tissue
transaminases.
Omar M.E. Abdel-Salam et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(12): 1181–11941192Our results thus indicate that cholinergic receptor blockade
with atropine was able to protect against the histopathological
alterations in the brain and liver and markedly inhibited DNA
damage in blood lymphocytes following acute malathion
exposure in rats. The mechanism probably involves decreased
oxidative stress that accompanied cholinesterase inhibition and
the excessive central and peripheral cholinergic stimulation. The
study also demonstrates for the ﬁrst time that the administration
of citrate was able to ameliorate the neurotoxicity and hepato-
toxicity as well as DNA damage caused by malathion. These
effects are likely to involve an antioxidant as well as a bio-
energetic action of citric acid. Citrate might thus ﬁnd a role in
treatment of nervous system consequences following exposure
to malathion and possibly other organophosphates.
Conﬂict of interest statement
We declare that we have no conﬂict of interest.
References
[1] Halliwell B. Biochemistry of oxidative stress. Biochem Soc Trans
2007; 35(Pt 5): 1147-1150.
[2] Weidinger A, Kozlov AV. Biological activities of reactive oxygen
and nitrogen species: oxidative stress versus signal transduction.
Biomolecules 2015; 5(2): 472-484.
[3] Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol
1997; 82(2): 291-295.
[4] Solsona C, Kahn TB, Badilla CL, A´lvarez-Zaldiernas C, Blasi J,
Fernandez JM, et al. Altered thiol chemistry in human amyotrophic
lateral sclerosis-linked mutants of superoxide dismutase 1. J Biol
Chem 2014; 289(39): 26722-26732.
[5] Markkanen E, Meyer U, Dianov GL. DNA damage and repair in
schizophrenia and autism: implications for cancer comorbidity and
beyond. Int J Mol Sci 2016; 17(6); http://dx.doi.org/10.3390/
ijms17060856.
[6] Peiro´ C, Romacho T, Azcutia V, Villalobos L, Ferna´ndez E,
Bolaños JP, et al. Inﬂammation, glucose, and vascular cell damage:
the role of the pentose phosphate pathway. Cardiovasc Diabetol
2016; 15(1): 82.
[7] Huang WJ, Zhang X, Chen WW. Role of oxidative stress in Alz-
heimer's disease. Biomed Rep 2016; 4(5): 519-522.
[8] Schieber M, Chandel NS. ROS function in redox signaling and
oxidative stress. Curr Biol 2014; 24(10): R453-R462.
[9] Delgado EH, Streck EL, Quevedo JL, Dal-Pizzol F. Mitochondrial
respiratory dysfunction and oxidative stress after chronic malathion
exposure. Neurochem Res 2006; 31(8): 1021-1025.
[10] Abdel-Salam OM, Youness ER, El-N Esmail RS, Mohammed NA,
Khadrawy YA, Sleem AA, et al. Methylene blue as a novel neu-
roprotectant in acute malathion intoxication. React Oxyg Species
2016; 1: 165-177.
[11] El-Bini Dhouib I, Lasram MM, Annabi A, Gharbi N, El-Fazaa S.
A comparative study on toxicity induced by carbosulfan and
malathion in Wistar rat liver and spleen. Pestic Biochem Physiol
2015; 124: 21-28.
[12] Karabag-Cobana F, Buldukb I, Limana R, Incec S, Cigercid I,
Hazmane O. Oleuropein alleviates malathion-induced oxidative
stress and DNA damage in rats. Toxicol Environ Chem 2016;
98(1): 101-108.
[13] John S, Kale M, Rathore N, Bhatnagar D. Protective effect of
vitamin E in dimethoate and malathion induced oxidative stress in
rat erythrocytes. J Nutr Biochem 2001; 12(9): 500-504.
[14] Trevisan R, Uliano-Silva M, Pandolfo P, Franco JL, Brocardo PS,
Santos AR, et al. Antioxidant and acetylcholinesterase response to
repeated malathion exposure in rat cerebral cortex and hippocam-
pus. Basic Clin Pharmacol Toxicol 2008; 102(4): 365-369.[15] Durak D, Uzun FG, Kalender S, Ogutcu A, Uzunhisarcikli M,
Kalender Y. Malathion-induced oxidative stress in human eryth-
rocytes and the protective effect of vitamins C and E in vitro.
Environ Toxicol 2009; 24(3): 235-242.
[16] German JB. Antioxidants. In: Branen AL, Davidson PM,
Salminen S, Thorngate JH III, editors. Food additives. 2nd ed. New
York, Basel: Marcel Dekker, Inc.; 2002, p. 538.
[17] Fromm HJ, Hargrove MS. The tricarboxylic acid cycle. In: Es-
sentials of biochemistry. Berlin Heidelberg: Springer-Verlag; 2012,
p. 205-221.
[18] Penniston KL, Nakada SY, Holmes RP, Assimos DG. Quantitative
assessment of citric acid in lemon juice, lime juice, and
commercially-available fruit juice products. J Endourol 2008;
22(3): 567-570.
[19] Franklin RB, Costello LC. Citrate metabolism in prostate and other
cancers. In: Singh KK, Costello LC, editors. Mitochondria and
cancer. Chicago: Springer; 2009, p. 61-78.
[20] Gabutti L, Ferrari N, Mombelli G, Keller F, Marone C. The
favorable effect of regional citrate anticoagulation on interleukin-
1beta release is dissociated from both coagulation and comple-
ment activation. J Nephrol 2004; 17(6): 819-825.
[21] Gritters M, Grooteman MP, Schoorl M, Schoorl M, Bartels PC,
Scheffer PG, et al. Citrate anticoagulation abolishes degranulation
of polymorphonuclear cells and platelets and reduces oxidative
stress during haemodialysis. Nephrol Dial Transpl 2006; 21(1):
153-159.
[22] Tiranathanagul K, Jearnsujitwimol O, Susantitaphong P,
Kijkriengkraikul N, Leelahavanichkul A, Srisawat N, et al.
Regional citrate anticoagulation reduces polymorphonuclear cell
degranulation in critically ill patients treated with continuous
venovenous hemoﬁltration. Ther Apher Dial 2011; 15(6): 556-564.
[23] Abdel-Salam OME, Youness ER, Mohammed NA, Morsy SMY,
Omara EA, Sleem AA. Citric acid effects on brain and liver
oxidative stress in lipopolysaccharide-treated mice. J Med Food
2014; 17(5): 588-598.
[24] Abdel Salam OME, Sleem AA, Shafﬁe NM. Hepatoprotective ef-
fects of citric acid and aspartame on carbon tetrachloride-induced
hepatic damage in rats. EXCLI J 2009; 8: 41-49.
[25] Abdel Salam OME, Sleem AA, Shafﬁe NM. Protection against
carbon tetrachloride-induced liver damage by citric acid. Cell Biol
Res Ther 2015; 4: 1.
[26] Kaur P, Radotra B, Minz RW, Gill KD. Impaired mitochondrial
energy metabolism and neuronal apoptotic cell death after chronic
dichlorvos (OP) exposure in rat brain. Neurotoxicology 2007;
28(6): 1208-1219.
[27] Middlemore-Risher ML, Adam BL, Lambert NA, Terry AV Jr.
Effects of chlorpyrifos and chlorpyrifos-oxon on the dynamics and
movement of mitochondria in rat cortical neurons. J Pharmacol
Exp Ther 2011; 339(2): 341-349.
[28] Karami-Mohajeri S, Hadian MR, Fouladdel S, Azizi E,
Ghahramani MH, Hosseini R, et al. Mechanisms of muscular
electrophysiological and mitochondrial dysfunction following
exposure to malathion, an organophosphorus pesticide. Hum Exp
Toxicol 2014; 33(3): 251-263.
[29] dos Santos AA, Naime AA, de Oliveira J, Colle D, dos Santos DB,
Hort MA, et al. Long-term and low-dose malathion exposure
causes cognitive impairment in adult mice: evidence of hippo-
campal mitochondrial dysfunction, astrogliosis and apoptotic
events. Arch Toxicol 2016; 90(3): 647-660.
[30] Bozkurt B, Dumlu EG, Tokac M, Ozkardes AB, Ergin M,
Orhun S, et al. Methylene blue as an antioxidant agent in
experimentally-induced injury in rat liver. Bratisl Lek Listy 2015;
116(3): 157-161.
[31] Roy Choudhury G, Winters A, Rich RM, Ryou MG, Gryczynski Z,
Yuan F, et al. Methylene blue protects astrocytes against glucose
oxygen deprivation by improving cellular respiration. PLoS One
2015; 10(4): e0123096.
[32] Jokanovic M. Medical treatment of acute poisoning with organo-
phosphorus and carbamate pesticides. Toxicol Lett 2009; 190(2):
107-115.
Omar M.E. Abdel-Salam et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(12): 1181–1194 1193[33] Eddleston M, Chowdhury FR. Pharmacological treatment of
organophosphorus insecticide poisoning: the old and the (possible)
new. Br J Clin Pharmacol 2016; 81(3): 462-470.
[34] Possamai FP, Fortunato JJ, Feier G, Agostinho FR, Quevedo J,
Wilhelm Filho D, et al. Oxidative stress after acute and sub-chronic
malathion intoxication in Wistar rats. Environ Toxicol Pharmacol
2007; 23(2): 198-204.
[35] Nel-H Zidan. Hepato- and nephrotoxicity in male albino rats
exposed to malathion and spinosad in stored wheat grains. Acta
Biol Hung 2015; 66(2): 133-148.
[36] Nair V, Turner GA. The thiobarbituric acid test for lipid peroxi-
dation: structure of the adduct with malondialdehyde. Lipids 1984;
19: 804-805.
[37] Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys
1959; 82(1): 70-77.
[38] Archer S. Measurement of nitric oxide in biological models.
FASEB J 1993; 7(2): 340-360.
[39] Eckerson HW, Wyte CM, La Du BN. The human serum para-
oxonase/arylesterase polymorphism. Am J Hum Genet 1983;
35(6): 1126-1138.
[40] Haagen L, Brock A. A new automated method for phenotyping
arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hy-
drolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin
Chem Clin Biochem 1992; 30(7): 391-395.
[41] Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. A new
and rapid colorimetric determination of acetylcholinesterase ac-
tivity. Biochem Pharmacol 1961; 7: 88-95.
[42] Gorun V, Proinov I, Baltescu V, Balaban G, Barzu O. Modiﬁed
Ellman procedure for assay of cholinesterases in crude enzymatic
preparations. Anal Biochem 1978; 86(1): 324-326.
[44] Singh NP, McCoy MT, Tice RR, Schneider EL. A simple tech-
nique for quantitation of low levels of DNA damage in individual
cells. Exp Cell Res 1988; 175(1): 184-191.
[45] Blasiak J, Gloc E, Drzewoski J, Wozniak K, Zadrozny M,
Sko´rski T, et al. Free radical scavengers can differentially modulate
the genotoxicity of amsacrine in normal and cancer cells.Mutat Res
2003; 535(1): 25-34.
[46] Elersek T, Filipic M. Organophosphorous pesticides-mechanisms
of their toxicity. In: Stoytcheva Margarita, editor. Pesticides-the
impacts of pesticides exposure; 2011; http://dx.doi.org/10.5772/
14020. Available from: http://www.intechopen.com/books/
pesticides-the-impacts-of-pesticidesexposure/organophosphorous-
pesticides-mechanisms-of-their-toxicity.
[47] Sullivan LB, Chandel NS. Mitochondrial reactive oxygen species
and cancer. Cancer Metab 2014; 2: 17.
[48] Holmstro¨m KM, Finkel T. Cellular mechanisms and physiological
consequences of redox-dependent signalling. Nat Rev Mol Cell Bio
2014; 15(6): 411-421.
[49] Attwell D, Laughlin SB. An energy budget for signaling in the
grey matter of the brain. J Cereb Blood Flow Metab 2001;
21(10): 1133-1145.
[50] Hertz L, Peng L, Dienel GA. Energy metabolism in astrocytes:
high rate of oxidative metabolism and spatiotemporal dependence
on glycolysis/glycogenolysis. J Cereb Blood Flow Metab 2007;
27(2): 219-249.
[51] Ying W, Chen Y, Alano CC, Swanson RA. Tricarboxylic acid
cycle substrates prevent PARP-mediated death of neurons and as-
trocytes. J Cereb Blood Flow Metab 2002; 22(7): 774-779.
[52] Inoue K, Zhuang L, Ganapathy V. Human Na+ -coupled citrate
transporter: primary structure, genomic organization, and transport
function. Biochem Biophys Res Commun 2002; 299(3): 465-471.
[53] Bryland A, Wieslander A, Carlsson O, Hellmark T, Godaly G,
Jones LM, et al. Gustatory processing: a dynamic systems
approach. Curr Opin Neurobiol 2006; 16(4): 420-428.
[54] Brekke E, Morken TS, Sonnewald U. Glucose metabolism and
astrocyte-neuron interactions in the neonatal brain. Neurochem Int
2015; 82: 33-41.
[55] Morciano P, Carrisi C, Capobianco L, Mannini L, Burgio G,
Cestra G, et al. A conserved role for the mitochondrial citratetransporter Sea/SLC25A1 in the maintenance of chromosome
integrity. Hum Mol Genet 2009; 18(21): 4180-4188.
[56] Sobrevia L, Ooi L, Ryan S, Steinert JR. Nitric oxide: a regulator of
cellular function in health and disease. Oxid Med Cell Longev
2016; 2016. 9782346.
[57] Wink DA, Feelisch M, Vodovotz Y, Fukuto J, Grisham MB. The
chemical biology of nitric oxide. In: Gilbert, Colton, editors.
Reactive oxygen species in biological systems. New York: Kluwer
Academic/Plenum Publishers; 1999, p. 245-291.
[58] Yuste JE, Tarragon E, Campuzano CM, Ros-Bernal F. Implications
of glial nitric oxide in neurodegenerative diseases. Front Cell
Neurosci 2015; 9: 322.
[59] Brown GC. Nitric oxide and neuronal death. Nitric Oxide 2010;
23(3): 153-165.
[60] La Du BN. Human serum paraoxonase/arylesterase. In: Kalow W,
editor. Pharmacogenetics of drug metabolism. New York: Perga-
mon Press, Inc.; 1992, p. 51-91.
[61] Kulka M. A review of paraoxonase 1 properties and diagnostic
applications. Pol J Vet Sci 2016; 19(1): 225-232.
[62] Jørgensen A, Nellemann C, Wohlfahrt-Veje C, Jensen TK,
Main KM, Andersen HR. Interaction between paraoxonase 1
polymorphism and prenatal pesticide exposure on metabolic
markers in children using a multiplex approach. Reprod Toxicol
2015; 51: 22-30.
[63] Carr RL, Dail MB, Chambers HW, Chambers JE. Species dif-
ferences in paraoxonase mediated hydrolysis of several organ-
ophosphorus insecticide metabolites. J Toxicol 2015; 2015.
470189.
[64] Holland N, Lizarraga D, Huen K. Recent progress in the ge-
netics and epigenetics of paraoxonase: why it is relevant to
children's environmental health. Curr Opin Pediatr 2015; 27(2):
240-247.
[65] Marsillach J, Costa LG, Furlong CE. Paraoxonase-1 and early-life
environmental exposures. Ann Glob Health 2016; 82(1): 100-110.
[66] McDaniel CY, Dail MB, Wills RW, Chambers HW,
Chambers JE. Paraoxonase 1 polymorphisms within a Mississippi
USA population as possible biomarkers of enzyme activities
associated with disease susceptibility. Biochem Genet 2014;
52(11–12): 509-523.
[67] Bernal-Herna´ndez YY, Medina-Díaz IM, Barro´n-Vivanco BS,
Robledo-Marenco Mde L, Giro´n-Pe´rez MI, Pe´rez-Herrera NE,
et al. Paraoxonase 1 and its relationship with pesticide biomarkers
in indigenous Mexican farmworkers. J Occup Environ Med 2014;
56(3): 281-290.
[68] Medina-Díaz IM, Ponce-Ruiz N, Ramírez-Cha´vez B, Rojas-
García AE, Barro´n-Vivanco BS, Elizondo G, et al. Downregulation
of human paraoxonase 1 (PON1) by organophosphate pesticides in
HepG2 cells. Environ Toxicol 2016; http://dx.doi.org/10.1002/
tox.22253.
[69] Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A,
et al. Human serum paraoxonases (PON1) Q and R selectively
decrease lipid peroxides in human coronary and carotid athero-
sclerotic lesions: PON1 esterase and peroxidase-like activities.
Circulation 2000; 101(21): 2510-2517.
[70] Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R,
Bisgaier CL, et al. Human serum paraoxonase (PON 1) is inacti-
vated by oxidized low density lipoprotein and preserved by anti-
oxidants. Free Radic Biol Med 1999; 26(7–8): 892-904.
[71] Nguyen SD, Sok DE. Oxidative inactivation of paraoxonase1, an
antioxidant protein and its effect on antioxidant action. Free Radic
Res 2003; 37(12): 1319-1330.
[72] Pohanka M. Inhibitors of acetylcholinesterase and butyr-
ylcholinesterase meet immunity. Int J Mol Sci 2014; 15: 9809-
9825.
[73] Silman I, Sussman JL. Acetylcholinesterase: ‘classical’ and ‘non-
classical’ functions and pharmacology. Curr Opin Pharmacol
2005; 5(3): 293-302.
[74] Çokugras¸ AN. Butyrylcholinesterase: structure and physiological
importance. Turk J Biochem 2003; 28(2): 54-61.
Omar M.E. Abdel-Salam et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(12): 1181–11941194[75] Delacour H, Dedome E, Courcelle S, Hary B, Ceppa F. Butyr-
ylcholinesterase deﬁciency. Ann Biol Clin (Paris) 2016; 74(3):
279-285.
[76] Shrayyef MZ, Gerich JE. Normal glucose homeostasis. In:
Poretsky L, editor. Principles of diabetes mellitus. Epub: Springer;
2010, p.19-34 [Epub].[77] Re´us GZ, Valvassori SS, Nuernberg H, Comim CM, Stringari RB,
Padilha PT, et al. DNA damage after acute and chronic treatment
with malathion in rats. J Agric Food Chem 2008; 56: 7560-7565.
[78] Ojha A, Srivastava N. In vitro studies on organophosphate pesti-
cides induced oxidative DNA damage in rat lymphocytes. Mutat
Res Genet Toxicol Environ Mutagen 2014; 761: 10-17.
